These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 373006)

  • 21. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract]   [Full Text] [Related]  

  • 22. Maintenance therapy and schizophrenia.
    Leff JP
    Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
    Bohacek N; Mihovilović M
    Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A; Ciurezu T; Cucu I
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
    Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK
    Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled trial of depot fluphenazine in out-patient schizophrenics.
    Crawford R; Forrest A
    Br J Psychiatry; 1974 Apr; 124(0):385-91. PubMed ID: 4599422
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with the depot neuroleptic LyogenR-depot].
    Bach O; Petermann H; Geppert V
    Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW; Kulhanek F
    Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinico-economical aspects of long-term therapy with moditen-depot].
    Ushakov IuV; Kravchenko NE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(12):67-9. PubMed ID: 1965375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of fluphenazine use since establishment of a psychiatric section].
    Roger BM
    Ann Med Psychol (Paris); 1972 Apr; 1(4):550-5. PubMed ID: 4342755
    [No Abstract]   [Full Text] [Related]  

  • 33. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting neuroleptics--a fairy story?
    Hiep A; Marriott P
    Nurs Times; 1976 Jun; 72(22):863-6. PubMed ID: 775449
    [No Abstract]   [Full Text] [Related]  

  • 35. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
    Weiser G; Gattringer B; Bengesser G
    Wien Med Wochenschr; 1973 Apr; 123(14):227-30. PubMed ID: 4695598
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 38. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA; Aderounmu AF
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluphenazine depot. The usefulness of neuroleptics in perspective].
    Malm U
    Nord Psykiatr Tidsskr; 1971; 25(4):309-14. PubMed ID: 5154115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.